ASCO 2024 Ascentage Pharma Releases Latest Results From Multiple Clinical Studies Of Its Lead Drug Candidates
(MENAFN- PR Newswire) SUZHOU, China and ROCKVILLE, Md., May 23, 2024 /PRNewswire/ -- Ascentage Pharma (6855), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related disease s, …